Anti-inflammatory therapies in atrial fibrillation [4] (multiple letters)

International Journal of Cardiology

Volumn 104, Issue 3, 2005, Pages 359-360

  Liu, Tong ^a   Li, Guang Ping ^a   Huang, Ti Gang ^a   Korantzopoulos, Panagiotis ^b,c   Kolettis, Theofilos M ^c   Kountouris, Evaggelos ^b  

^a SECOND HOSPITAL OF TIANJIN MEDICAL UNIVERSITY   (China)

^b G HATZIKOSTA GENERAL HOSPITAL   (Greece)

^c UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIINFLAMMATORY AGENT; ASCORBIC ACID; ATENOLOL; ATORVASTATIN; BLOCKING AGENT; C REACTIVE PROTEIN; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FISH OIL; GLUCOCORTICOID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METOPROLOL; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA 3 FATTY ACID; PRAVASTATIN; SPIRONOLACTONE;

CARDIOVERSION; CLINICAL PRACTICE; CORONARY ARTERY BYPASS GRAFT; DEATH; FIBROSIS; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HUMAN; INFLAMMATION; LETTER; OXIDATIVE STRESS; PATHOGENESIS; PERICARDITIS; PRIORITY JOURNAL; RECURRENCE RISK; RISK; SINUS RHYTHM; STROKE;

EID: 25444472317     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.05.074     Document Type: Article

References (15)

1. P. Korantzopoulos D. Galaris D. Papaioannides S. Kokkoris C-reactive protein and oxidative stress in atrial fibrillation Int J Cardiol 88 2003 103 104
2. T. Liu G.P. Li Is atrial fibrillation an inflammatory disease? Med Hypotheses 64 2005 1237 1238
3. R.J. Aviles D.O. Martin C. Apperson-Hansen Inflammation as a risk factor for atrial fibrillation Circulation 108 2003 3006 3010
4. F.W. Asselbergs M.P. van den Berg G.F.H. Diercks W.H. van Gilst D.J. van Veldhuisen C-reactive protein and microalbuminuria are associated with atrial fibrillation Int J Cardiol 98 2005 73 77
5. P. Korantzopoulos T.M. Kolettis E. Kountouris Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation Int J Cardiol 102 2005 321 326
6. P. Korantzopoulos S. Kokkoris The antioxidant effects of statins may extend beyond atherosclerosis: potential benefits for atrial fibrillation and heart failure Atherosclerosis 175 2004 187
7. K. Kumagai H. Nakashima K. Saku The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model Cardiovasc Res 62 2004 105 111
8. A. Tveit M. Grundtvig T. Gundersen Analysis of pravastatin to prevent recurrence of atrial fibrillation after electrical cardioversion Am J Cardiol 93 2004 780 782
9. J.C. Merritt M. Niebauer K. Tarakji D. Hammer R.M. Mills Comparison of effectiveness of carvedilol versus metoprolol or atenolol for atrial fibrillation appearing after coronary artery bypass grafting or cardiac valve operation Am J Cardiol 92 2003 735 736
10. J. Dernellis M. Panaretou Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation Eur Heart J 25 2004 1100 1107
11. K.K. Cheruku A. Ghani F. Ahmad Efficacy of nonsteroidal anti-inflammatory medications for prevention of atrial fibrillation following coronary artery bypass graft surgery Prev Cardiol 7 2004 13 18
12. V. da Cunha D.M. Tham B. Martin-McNulty Enalapril attenuates angiotensin II-induced atherosclerosis and vascular inflammation Atherosclerosis 178 2005 9 17
13. T.A. Mori L.J. Beilin Omega-3 fatty acids and inflammation Curr Atheroscler Rep 6 2004 461 467
14. J.S. Healey C.A. Morillo S.J. Connolly Role of the renin-angiotensin-aldosterone system in atrial fibrillation and cardiac remodeling Curr Opin Cardiol 20 2005 31 37
15. D. Mozaffarian B.M. Psaty E.B. Rimm Fish intake and risk of incident atrial fibrillation Circulation 110 2004 368 373